Vaxil Bio Statistics

Total Valuation

Vaxil Bio has a market cap or net worth of CAD 671,197. The enterprise value is 268,196.

Market Cap	671,197
Enterprise Value	268,196

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Vaxil Bio has 2.74 million shares outstanding.

Current Share Class	2.74M
Shares Outstanding	2.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.17%
Owned by Institutions (%)	0.01%
Float	2.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.04
P/TBV Ratio	1.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.41
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.10

Current Ratio	17.10
Quick Ratio	10.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.69% and return on invested capital (ROIC) is -17.92%.

Return on Equity (ROE)	-25.69%
Return on Assets (ROA)	-16.39%
Return on Invested Capital (ROIC)	-17.92%
Return on Capital Employed (ROCE)	-32.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.00% in the last 52 weeks. The beta is -1.45, so Vaxil Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.45
52-Week Price Change	-51.00%
50-Day Moving Average	0.60
200-Day Moving Average	0.76
Relative Strength Index (RSI)	37.04
Average Volume (20 Days)	4,414

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-212,000
Pretax Income	-190,000
Net Income	-190,000
EBITDA	n/a
EBIT	-212,000
Earnings Per Share (EPS)	-0.07

Full Income Statement

Balance Sheet

The company has 403,000 in cash and n/a in debt, giving a net cash position of 403,000 or 0.15 per share.

Cash & Cash Equivalents	403,000
Total Debt	n/a
Net Cash	403,000
Net Cash Per Share	0.15
Equity (Book Value)	644,000
Book Value Per Share	0.24
Working Capital	644,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-267,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vaxil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-28.31%
FCF Yield	n/a

Stock Splits

The last stock split was on May 15, 2025. It was a reverse split with a ratio of 0.02.

Last Split Date	May 15, 2025
Split Type	Reverse
Split Ratio	0.02

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a